- Tixagevimab and Cilgavimab: The US FDA has withdrawn emergency-use authorization for tixagevimab and cilgavimab due to lack of efficacy, and no information is available on their use during breastfeeding. It is likely that the amount in milk would be very low.
- Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December,: This rapid living systematic evidence synthesis and meta-analysis examined the long-term vaccine effectiveness of BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), ChAdOx1 nCoV-19 (AZD1222; Oxford-AstraZeneca), and Ad26.COV2.S (Janssen) against infections, hospitalizations, and mortality. EMBASE and the US National Institutes of Health’s iSearch COVID-19 Portfolio were searched for relevant studies.
- From Olive Oil Emulsions to COVID-19 Vaccines: Liposomes Came First: The journey from Pliny the Elder’s (23-79 AD) use of olive oil on seawater to the FDA approval of the first injectable nanomedicine in 1997 was driven by intellectual curiosity and the work of gifted hands and motivated brains. This review highlights how a curious discovery made under a microscope has led to novel nanotherapeutics.
Daily News Pulse for March 13, 2023
Summary: Princeton students have seen an overall improvement in course satisfaction since the start of the COVID-19 pandemic. In Japan, many people are still wearing masks despite the government’s easing of guidelines.
